Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Torres-Ferrus

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cephalalgia : an International Journal of Headache|November 24, 2019
When does chronic migraine strike?Patricia Pozo-Rosich, Marta Torres-Ferrus
Current Opinion in Neurology|April 6, 2019
How much do calcitonin gene-related peptide monoclonal antibodies improve the quality of life in migraine? A patient's perspectiveMarta Torres-Ferrus, Alicia Alpuente, Patricia Pozo-Rosich
Headache|August 7, 2021
Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenariosEdoardo Caronna, Alicia Alpuente, Marta Torres-Ferrus, et al.
Current Opinion in Neurology|March 26, 2024
The state of art on the use of patient reported outcomes in migraineAlicia Alpuente, Marta Torres-Ferrus, Edoardo Caronna, et al.
Handbook of Clinical Neurology|February 2, 2024
CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine preventionEdoardo Caronna, Alicia Alpuente, Marta Torres-Ferrus, et al.
The Journal of Headache and Pain|July 13, 2020
Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinAMarta Torres-Ferrus, Victor José Gallardo, Alicia Alpuente, et al.
Headache|November 2, 2022
Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative reviewJavier A Membrilla, Marta Torres-Ferrus, Alicia Alpuente, et al.
The Journal of Headache and Pain|December 14, 2021
In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence studyAlicia Alpuente, Victor J Gallardo, Edoardo Caronna, et al.
The Journal of Headache and Pain|October 8, 2021
Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 monthsEdoardo Caronna, Victor José Gallardo, Alicia Alpuente, et al.
Journal of Neurology|July 20, 2021
Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainabilityEdoardo Caronna, Victor José Gallardo, Alicia Alpuente, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cephalalgia : an International Journal of Headache|November 24, 2019
When does chronic migraine strike?Patricia Pozo-Rosich, Marta Torres-Ferrus
Current Opinion in Neurology|April 6, 2019
How much do calcitonin gene-related peptide monoclonal antibodies improve the quality of life in migraine? A patient's perspectiveMarta Torres-Ferrus, Alicia Alpuente, Patricia Pozo-Rosich
Headache|August 7, 2021
Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenariosEdoardo Caronna, Alicia Alpuente, Marta Torres-Ferrus, et al.
Current Opinion in Neurology|March 26, 2024
The state of art on the use of patient reported outcomes in migraineAlicia Alpuente, Marta Torres-Ferrus, Edoardo Caronna, et al.
Handbook of Clinical Neurology|February 2, 2024
CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine preventionEdoardo Caronna, Alicia Alpuente, Marta Torres-Ferrus, et al.
The Journal of Headache and Pain|July 13, 2020
Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinAMarta Torres-Ferrus, Victor José Gallardo, Alicia Alpuente, et al.
Headache|November 2, 2022
Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative reviewJavier A Membrilla, Marta Torres-Ferrus, Alicia Alpuente, et al.
The Journal of Headache and Pain|December 14, 2021
In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence studyAlicia Alpuente, Victor J Gallardo, Edoardo Caronna, et al.
The Journal of Headache and Pain|October 8, 2021
Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 monthsEdoardo Caronna, Victor José Gallardo, Alicia Alpuente, et al.
Journal of Neurology|July 20, 2021
Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainabilityEdoardo Caronna, Victor José Gallardo, Alicia Alpuente, et al.
Pageof 4